(14971513), A. O., (14971516), R. C., (14971519), G. v. A., (14971522), C. R., (14971525), S. F., (14971528), W. L., . . . (14971558), M. J. (2025). Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer.
Chicago (17e ed.) Bronvermelding(14971513), Aurelius Omlin, et al. Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer. 2025.
MLA (9e ed.) Bronvermelding(14971513), Aurelius Omlin, et al. Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer. 2025.